Intravenous r-TPA in vertebrobasilar acute infarcts

@article{Montavont2004IntravenousRI,
  title={Intravenous r-TPA in vertebrobasilar acute infarcts},
  author={Alexandra Montavont and Norbert Nighoghossian and Laurent Derex and Marc Hermier and J{\'e}r{\^o}me Honnorat and Fr{\'e}d{\'e}ric Philippeau and M{\'a}rcia Belo and Francis Turjman and Patrice Adeleine and J. C. Froment and Paul Trouillas},
  journal={Neurology},
  year={2004},
  volume={62 10},
  pages={1854-6}
}
Presented are the clinical data of 18 consecutive patients who were treated by IV recombinant tissue plasminogen activator (r-TPA) for suspected vertebrobasilar (VB) acute ischemia within 7 hours. The mean delay for treatment was 5 +/- 3.6 hours. Mean baseline NIH Stroke Scale score was 17 +/- 4. At 3 months, 10 patients were independent (modified Rankin Scale [mRS] score = 0 to 2), whereas 8 patients showed a poor outcome (mRs = 3 to 6). IV r-TPA in VB ischemia in a 7-hour window may be safe… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Vertebrobasilar disease.

The New England journal of medicine • 2005

Similar Papers

Loading similar papers…